» Articles » PMID: 3890880

Lipid Polymorphism: the Molecular Basis of Nonbilayer Phases

Overview
Publisher Annual Reviews
Date 1985 Jan 1
PMID 3890880
Citations 53
Authors
Affiliations
Soon will be listed here.
Citing Articles

Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models - a comprehensive review.

Idres Y, Idris A, Gao W Drug Deliv Transl Res. 2025; .

PMID: 40000558 DOI: 10.1007/s13346-025-01815-x.


Recent Advances in Lipid Nanoparticles for Delivery of mRNA.

Yang L, Gong L, Wang P, Zhao X, Zhao F, Zhang Z Pharmaceutics. 2022; 14(12).

PMID: 36559175 PMC: 9787894. DOI: 10.3390/pharmaceutics14122682.


The role of lipid components in lipid nanoparticles for vaccines and gene therapy.

Hald Albertsen C, Kulkarni J, Witzigmann D, Lind M, Petersson K, Simonsen J Adv Drug Deliv Rev. 2022; 188:114416.

PMID: 35787388 PMC: 9250827. DOI: 10.1016/j.addr.2022.114416.


Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.

Carrasco M, Alishetty S, Alameh M, Said H, Wright L, Paige M Commun Biol. 2021; 4(1):956.

PMID: 34381159 PMC: 8358000. DOI: 10.1038/s42003-021-02441-2.


Lipids and Lipid Derivatives for RNA Delivery.

Zhang Y, Sun C, Wang C, Jankovic K, Dong Y Chem Rev. 2021; 121(20):12181-12277.

PMID: 34279087 PMC: 10088400. DOI: 10.1021/acs.chemrev.1c00244.